Your browser doesn't support javascript.
loading
Subcellular specificity of cannabinoid effects in striatonigral circuits.
Soria-Gomez, Edgar; Pagano Zottola, Antonio C; Mariani, Yamuna; Desprez, Tifany; Barresi, Massimo; Bonilla-Del Río, Itziar; Muguruza, Carolina; Le Bon-Jego, Morgane; Julio-Kalajzic, Francisca; Flynn, Robyn; Terral, Geoffrey; Fernández-Moncada, Ignacio; Robin, Laurie M; Oliveira da Cruz, José F; Corinti, Simone; Amer, Yasmine Ould; Goncalves, Julia; Varilh, Marjorie; Cannich, Astrid; Redon, Bastien; Zhao, Zhe; Lesté-Lasserre, Thierry; Vincent, Peggy; Tolentino-Cortes, Tarson; Busquets-García, Arnau; Puente, Nagore; Bains, Jaideep S; Hebert-Chatelain, Etienne; Barreda-Gómez, Gabriel; Chaouloff, Francis; Lohman, Alexander W; Callado, Luis F; Grandes, Pedro; Baufreton, Jerome; Marsicano, Giovanni; Bellocchio, Luigi.
Afiliación
  • Soria-Gomez E; INSERM, U1215 NeuroCentre Magendie, Endocannabinoids and Neuroadaptation, Bordeaux, France; University of Bordeaux, Bordeaux, France; Department of Neurosciences, Faculty of Medicine and Nursing, University of the Basque Country UPV/EHU, Leioa, Spain; Achucarro Basque Center for Neuroscience, Leioa,
  • Pagano Zottola AC; INSERM, U1215 NeuroCentre Magendie, Endocannabinoids and Neuroadaptation, Bordeaux, France; University of Bordeaux, Bordeaux, France.
  • Mariani Y; INSERM, U1215 NeuroCentre Magendie, Endocannabinoids and Neuroadaptation, Bordeaux, France; University of Bordeaux, Bordeaux, France.
  • Desprez T; INSERM, U1215 NeuroCentre Magendie, Endocannabinoids and Neuroadaptation, Bordeaux, France; University of Bordeaux, Bordeaux, France.
  • Barresi M; University of Bordeaux, Bordeaux, France; IMN-UMR CNRS 5293 Neurodegenerative Diseases Institute, Bordeaux, France.
  • Bonilla-Del Río I; Department of Neurosciences, Faculty of Medicine and Nursing, University of the Basque Country UPV/EHU, Leioa, Spain; Achucarro Basque Center for Neuroscience, Leioa, Spain.
  • Muguruza C; Department of Pharmacology, University of the Basque Country UPV/EHU, Leioa, Spain; Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Madrid, Spain.
  • Le Bon-Jego M; University of Bordeaux, Bordeaux, France; IMN-UMR CNRS 5293 Neurodegenerative Diseases Institute, Bordeaux, France.
  • Julio-Kalajzic F; INSERM, U1215 NeuroCentre Magendie, Endocannabinoids and Neuroadaptation, Bordeaux, France; University of Bordeaux, Bordeaux, France.
  • Flynn R; Department of Cell Biology and Anatomy, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada; Hotchkiss Brain Institute, University of Calgary, Calgary, AB, Canada.
  • Terral G; INSERM, U1215 NeuroCentre Magendie, Endocannabinoids and Neuroadaptation, Bordeaux, France; University of Bordeaux, Bordeaux, France.
  • Fernández-Moncada I; INSERM, U1215 NeuroCentre Magendie, Endocannabinoids and Neuroadaptation, Bordeaux, France; University of Bordeaux, Bordeaux, France.
  • Robin LM; INSERM, U1215 NeuroCentre Magendie, Endocannabinoids and Neuroadaptation, Bordeaux, France; University of Bordeaux, Bordeaux, France.
  • Oliveira da Cruz JF; INSERM, U1215 NeuroCentre Magendie, Endocannabinoids and Neuroadaptation, Bordeaux, France; University of Bordeaux, Bordeaux, France.
  • Corinti S; INSERM, U1215 NeuroCentre Magendie, Endocannabinoids and Neuroadaptation, Bordeaux, France; University of Bordeaux, Bordeaux, France.
  • Amer YO; Canada Research Chair in Mitochondrial Signaling and Physiopathology, Department of Biology, University of Moncton, Moncton, NB, Canada.
  • Goncalves J; INSERM, U1215 NeuroCentre Magendie, Endocannabinoids and Neuroadaptation, Bordeaux, France; University of Bordeaux, Bordeaux, France.
  • Varilh M; INSERM, U1215 NeuroCentre Magendie, Endocannabinoids and Neuroadaptation, Bordeaux, France; University of Bordeaux, Bordeaux, France.
  • Cannich A; INSERM, U1215 NeuroCentre Magendie, Endocannabinoids and Neuroadaptation, Bordeaux, France; University of Bordeaux, Bordeaux, France.
  • Redon B; INSERM, U1215 NeuroCentre Magendie, Endocannabinoids and Neuroadaptation, Bordeaux, France; University of Bordeaux, Bordeaux, France.
  • Zhao Z; INSERM, U1215 NeuroCentre Magendie, Endocannabinoids and Neuroadaptation, Bordeaux, France; University of Bordeaux, Bordeaux, France.
  • Lesté-Lasserre T; INSERM, U1215 NeuroCentre Magendie, Endocannabinoids and Neuroadaptation, Bordeaux, France; University of Bordeaux, Bordeaux, France.
  • Vincent P; INSERM, U1215 NeuroCentre Magendie, Endocannabinoids and Neuroadaptation, Bordeaux, France; University of Bordeaux, Bordeaux, France.
  • Tolentino-Cortes T; Department of Research and Development, IMG Pharma Biotech S.L., Derio, Spain.
  • Busquets-García A; INSERM, U1215 NeuroCentre Magendie, Endocannabinoids and Neuroadaptation, Bordeaux, France; University of Bordeaux, Bordeaux, France.
  • Puente N; Department of Neurosciences, Faculty of Medicine and Nursing, University of the Basque Country UPV/EHU, Leioa, Spain; Achucarro Basque Center for Neuroscience, Leioa, Spain.
  • Bains JS; Hotchkiss Brain Institute, University of Calgary, Calgary, AB, Canada.
  • Hebert-Chatelain E; Canada Research Chair in Mitochondrial Signaling and Physiopathology, Department of Biology, University of Moncton, Moncton, NB, Canada.
  • Barreda-Gómez G; Department of Research and Development, IMG Pharma Biotech S.L., Derio, Spain.
  • Chaouloff F; INSERM, U1215 NeuroCentre Magendie, Endocannabinoids and Neuroadaptation, Bordeaux, France; University of Bordeaux, Bordeaux, France.
  • Lohman AW; Department of Cell Biology and Anatomy, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada; Hotchkiss Brain Institute, University of Calgary, Calgary, AB, Canada; Alberta Children's Hospital Research Institute, University of Calgary, Calgary, AB, Canada.
  • Callado LF; Department of Pharmacology, University of the Basque Country UPV/EHU, Leioa, Spain; Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Madrid, Spain; Biocruces Bizkaia Health Research Institute, Barakaldo, Spain.
  • Grandes P; Department of Neurosciences, Faculty of Medicine and Nursing, University of the Basque Country UPV/EHU, Leioa, Spain; Achucarro Basque Center for Neuroscience, Leioa, Spain; Division of Medical Sciences, University of Victoria, Victoria, BC, Canada.
  • Baufreton J; University of Bordeaux, Bordeaux, France; IMN-UMR CNRS 5293 Neurodegenerative Diseases Institute, Bordeaux, France.
  • Marsicano G; INSERM, U1215 NeuroCentre Magendie, Endocannabinoids and Neuroadaptation, Bordeaux, France; University of Bordeaux, Bordeaux, France. Electronic address: giovanni.marsicano@inserm.fr.
  • Bellocchio L; INSERM, U1215 NeuroCentre Magendie, Endocannabinoids and Neuroadaptation, Bordeaux, France; University of Bordeaux, Bordeaux, France. Electronic address: luigi.bellocchio@inserm.fr.
Neuron ; 109(9): 1513-1526.e11, 2021 05 05.
Article en En | MEDLINE | ID: mdl-33770505
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Encéfalo / Transducción de Señal / Transmisión Sináptica / Receptor Cannabinoide CB1 Límite: Animals / Humans / Male Idioma: En Revista: Neuron Asunto de la revista: NEUROLOGIA Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Encéfalo / Transducción de Señal / Transmisión Sináptica / Receptor Cannabinoide CB1 Límite: Animals / Humans / Male Idioma: En Revista: Neuron Asunto de la revista: NEUROLOGIA Año: 2021 Tipo del documento: Article